Diethyl spiro[3.3]heptane-2,6-dicarboxylate, 95.0%, 5g

2-Chloroacetanilide, 95.0%, 25g

4-(Methylsulfonylamino)phenylboronic acid, 95.0%, 5g

4,4,5,5-Tetramethyl-2-[3-(trifluoromethoxy)phenyl]-1,3,2-dioxaborolane>98.0%(GC)(T)5g

6-Propyl-3H-thieno[2,3-d]pyrimidin-4-one, 5g

Uric acid, 95.0%, 100g

2-(4,4-Difluorocyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

Petri dishes with aeration lugs, 90 x 16 mm, Non-sterile 480 pcs

3-(6-CHLORO-[1,2,4]TRIAZOLO[3,4-A]PHTHALAZIN-3-YL)-5-METHYLISOXAZOLE, 95%, 1g

Methyl 4-iodopyridine-2-carboxylate, 95.0%, 1g

4-Bromo-2-chlorothiazole, 95.0%, 250mg

2,5-Dichloro-4-iodopyridine, 95.0%, 100g

(S)-2-((tert-Butoxycarbonyl)amino)-6-formamidohexanoic acid, 95.0%, 5g